MONOCLONAL-ANTIBODY ADMINISTRATION - CURRENT CLINICAL PHARMACOKINETIC STATUS AND FUTURE-TRENDS

被引：11
|
作者：
HENRY, R [1 ]
BEGENT, J [1 ]
PEDLEY, RB [1 ]
机构：
[1] UNIV LONDON, ROYAL FREE HOSP,SCH MED,DEPT CLIN ONCOL, CLIN RES LABS,CANC RES CAMPAIGN, LONDON NW3 2PF, ENGLAND
来源：
CLINICAL PHARMACOKINETICS | 1992年 / 23卷 / 02期
关键词：
D O I：
10.2165/00003088-199223020-00001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Antibody targeting depends on successful manipulation of pharmacokinetics. The last decade has produced many means of achieving this and the successes now being reported in targeted cancer therapy are likely to be improved on by the newer technologies which are coming to clinical trial. © 1992, Adis International Limited. All rights reserved.
引用
收藏
页码：85 / 89
页数：5
相关论文
共 50 条
12345